Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2010

View Archived Issues

Roche discovers new inverse agonists of GABA(A) alpha5 receptor

Merck KGaA divulges novel inhibitors of protein kinases

Preliminary efficacy reported in first-in-human trial of LFB-R603 in chronic lymphocytic leukemia

Interim data from phase I trial of PF-03732010 in advanced solid tumors reveal good tolerability

Oncolytic prodrug BMS-817378 selected for clinical development

Activity seen with ARRY-520 in patients with relapsed/refractory multiple myeloma

ACT Biotech describes activity of Aurora kinase inhibitor ACTB-1010

Phase II results for plitidepsin in peripheral T-cell lymphoma presented

The Leukemia and Lymphoma Society provides support to BioTheryX

Case Western Reserve University licenses insulin analogues to Thermalin Diabetes

MorphoSys and Xencor start phase I study of MOR-208 in chronic lymphocytic leukemia

Cell Therapeutics appeals FDA decision on pixantrone NDA for non-Hodgkin's lymphoma

Cyrenaic reports results from phase IIa CYR-101 trial in schizophrenia

Agios Pharmaceuticals describes novel pyruvate kinase M2 activators

Insmed and Transave enter into business combination

Geron begins phase II imetelstat trial in breast cancer

Forest Laboratories discloses novel acetyl-CoA carboxylase inhibitors

New antibacterials created by UMDNJ and Rutgers scientists

BioMarin receives U.K. approval for clinical trial of BMN-673 in genetically defined cancers

Cynapsus reports data for Parkinson's drug candidate APL-130277

QR Pharma cleared to conduct clinical trials with bisnorcymserine for AD

Long-term phase III study confirms efficacy of avanafil for erectile dysfunction

Prochieve 8% reduces incidence of preterm birth in phase III study

FDA accepts for review sBLA for subcutaneous Orencia

Pfizer plans 2011 regulatory submissions for bosutinib in CML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...